Controversial FDA official leaving drug center post in latest departure at agency

The leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs is leaving her post, a senior FDA official confirmed to CBS News, marking the latest high-level shake-up at the FDA. Dr. Tracy Beth Høeg had served as acting director of the FDA's Center for Drug Evaluation and Research (CDER) since December, helming an office that reviews applications for new drugs. She previously advised former FDA Commissioner Dr. Marty Makary. …